Back to Search Start Over

Oxford–AstraZeneca COVID-19 vaccine: need of a reasoned and effective vaccine campaign.

Authors :
Vallée, A.
Chan-Hew-Wai, A.
Bonan, B.
Lesprit, P.
Parquin, F.
Catherinot, É.
Choucair, J.
Billard, D.
Amiel-Taieb, C.
Camps, È.
Cerf, C.
Zucman, D.
Fourn, E.
Source :
Public Health (Elsevier). Jul2021, Vol. 196, p135-137. 3p.
Publication Year :
2021

Abstract

A strong COVID-19 vaccine campaign is needed to reach the herd immunity and reduce this pandemic infection. In the Foch Hospital, France, in February 2021, 451 healthcare workers were vaccinated by a first dose of AstraZeneca vaccine. Adverse effects were reported to our pharmaco-vigilance circuit, by an online and anonymous questionnaire following the first weeks of the vaccinal campaign to healthcare workers. Two hundred seventy-four (60.8%) of them reported multiple adverse effects. Main adverse effects reported were feverish state/chills (65.7%), fatigue/physical discomfort (62.4%), arthralgia/muscle pain (61.0%) and fever (44.5%). On March 2021 many European countries suspended AstraZeneca vaccine for one week due to safety uncertainty. Thus, confidence in its efficacy is undermined. However, the benefit/risk balance is clearly in favor of vaccination. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
00333506
Volume :
196
Database :
Academic Search Index
Journal :
Public Health (Elsevier)
Publication Type :
Academic Journal
Accession number :
151701211
Full Text :
https://doi.org/10.1016/j.puhe.2021.05.030